LGALS3 and B-cell chronic lymphocytic leukemia: On the contrary, the ZAP-70-positive group of CLL patients had a significantly (p < 0.001) higher percentage of B lymphocytes expressing Gal-3 compared to the ZAP-70-negative group (Figure 5C).